Mouse NK cells may use both cytokine, e.g. IFN-γ, tumor necrosis factor (TNF)-α and IL-12, and cytotoxic, e.g. perforin and Fas-FasL, pathways to reject incompatible bone marrow cell (BMC) grafts. To begin a dissection of these two major pathways, mice bearing deletional mutations of IFN-γ, TNF-RI/II or perforin, or mice treated with mAb to IL-12, IFN-γ or NK1.1 were irradiated and challenged with class I-deficient BMC grafts, a system in which only NK cells are the effector cells. Proliferation of the donor-derived cells was judged in terms of splenic incorporation of [ 125 I]iododeoxyuridine 5 or 7 days after cell transfer. All of these mice maintained in a specific pathogen-free (s.p.f.) environment were able to reject the BMC, except those treated with anti-NK1
Introduction
NK cells are the major effector cells that reject murine bone marrow cells (BMC) rapidly (1), although CD8 ϩ T cells can also participate (2) . There are two basic pathways by which rejection may occur-cytokine secretion and cellular cytotoxicity. Because the perforin and Fas-FasL systems of cell cytotoxicity are major mechanisms used by NK and CD8 ϩ T cells (3) (4) (5) (6) (7) , mice with defects in these systems were tested for the ability to reject H-2 d allogeneic BMC allografts. No significant defects were detected (8) . The mice used in those Correspondence to: M. Bennett Transmitting editor: I. L. Weissman Received 31 July 1997, accepted 17 February 1998 experiments were of the C57BL/6 background and were maintained in a specific-pathogen-free (s.p.f.) environment. These perforin gene 'knockout' (PKO) mice were derived from a C57BL/6 (B6) H-2 b embryonic stem cell. The findings were quite surprising and led to speculations that either cytokine (non-cytotoxic) or non-Fas, non-perforin cytotoxic, mechanisms were used by NK cells or CD8 ϩ T cells to reject BMC grafts. Similar observations were made with granzyme Adiptheria toxin transgeneic mice that deletes granzyme A-expressing (NK/cytotoxic T) cells (9) . Cytokines secreted by NK cells (10, 11) that might inhibit hemopoiesis include IFN-γ, tumor necrosis factor (TNF)-α or IL-12 (12) (13) (14) (15) (16) (17) (18) . It should be mentioned, on balance, that some of the same studies showed that IFN-γ, TNF-α or IL-12 can also stimulate early stages of hemopoiesis. Cytotoxic mechanisms, e.g. FasFasL, TNF-α or lymphotoxin-TNF-β (19) (20) (21) (22) (23) (24) (25) (26) , may operate in the absence of perforin. We report here studies designed to identify other possible mechanisms of BMC graft rejection.
We have used PKO mice derived from 129 H-2 b strain embryonic stem cells developed by Manley Huang at GenPharm (5). These mice were crossed with B6 mice to obtain animals that inherited the NK1. (31) . The values are expressed in terms of geometric mean percentage uptake of the radiolabel. The 95% confidence limits were also calculated (but not presented in the tables). Statistical analyses were performed, using log 10 values. Both parametric and non-parametric analyses were performed (groups of five to eight mice).
Results
Grafts of β 2 m KO BMC in mice maintained in a s.p.f. environment (Table 1) Four experiments are reported, beginning with results of BMC grafts into mice with deficits in cytokine secretion or responsiveness (Experiment 1). Grafts of 5ϫ10 6 β 2 m KO BMC grew well in syngeneic hosts (Experiment 3) and in all β 2 mϩ/ ϩ hosts treated with anti-NK1.1 mAb (except NK1.1 -129 hosts, Experiment 3), and were rejected by B6, 129 and (B6ϫ129)F 2 ϩ/ϩ hosts (Experiment 1-5). The rejection of class I-deficient BMC by NK effector cells is confirmed by these results. B6 IFN-γ and TNF-RI/II KO mice strongly rejected the BMC (Experiment 1). Moreover, anti-NK1.1, but not ant-IFN-γ or anti-IL-12, mAb reversed rejection. Therefore, severe deficiencies in cytokine secretion, availability or responsiveness failed to prevent rejection of class I-deficient BMC by NK cells, at least in s.p.f. mice with intact cytotoxic mechanisms. Moreover, 129:B6 PKO mice with a defect in cytotoxicity rejected β 2 m KO BMC, and anti-IFN-γ and anti-IL-12 mAb failed to reverse rejection; B6 PKO mice also rejected the class I-deficient BMC (Experiment 2). These mice had cytotoxic defects and were depleted of either IFN-γ or IL-12, potentially critical cytokines. B6 gld/gld and B6 PKO mice resisted engraftment of these BMC (Experiment 3). 129:B6 PKO mice rejected β 2 m KO BMC when assayed at day (10); this is not reversal of rejection because growth is robust in untreated mice.
5, but growth was detected when the assay was performed at day 7 (Experiment 5). The extra 2 days allowed for about four more doublings times of erythropoietic cells (31) . Therefore the assay for growth on day 7 was equivalent to infusing 15-20ϫ10 6 BMC for a 5-day assay. The relative poor effect of anti-NK1.1 in (B6ϫ129)F 2 hosts in Experiment 3 could have been due to the potential predominance of mice which were NK1.1 -, as are 129 mice. Thus, only at 7 days was there a deficiency detected in 129:B6 PKO hosts (compare Experiments 2 and 3 with Experiment 5). Nevertheless, 'good rejector' B6ϩ/ϩ mice (31) did reject the grafts at days 5 or 7. Grafts of Tap-1 KO BMC in mice maintained in conventional or s.p.f., or in mice transferred from a s.p.f. to a conventional, environment ( Table 2 ).
The observations that 129:B6 mice in a s.p.f. environment could resist the engraftment of class I-deficient BMC grafts suggested that the breeding/housing environment may influence the ability of PKO mice to resist BMC grafts. To test that possibility, 129:B6 PKO mice were shipped from Minnesota to Dallas and placed in a s.p.f. environment. One week later, 30 mice were transferred to the conventional colony. On days 4, 10, 18 and 32, the transferred (s.p.f. to conventional), as well as s.p.f. (Minnesota) and conventional (Dallas), 129:B6 PKO mice were irradiated and challenged with class Ideficient Tap-1 KO BMC. Tap-1 KO mice were used because of their availability in the Dallas facility. The s.p.f. mice were kept in microisolator cages and were irradiated separately in a sterile container. All isotope assays were performed 5 days after cell transfer. The conventionally housed 129:B6 PKO mice always accepted the BMC grafts from Tap-1 KO donors (Experiments 1-4); in contrast, the 129:B6 PKO mice from Minnesota maintained in a s.p.f. environment always rejected the Tap-1 KO BMC grafts. The mice transferred from the s.p.f. to the conventional facility remained totally resistant to Tap-1 KO BMC until day 32. At that time three of five were susceptible to engraftment while two of five remained resistant (Experiment 4). B6ϩ/ϩ mice raised in a conventional environment consistently resisted engraftment (Experiments 1-4) and this resistance was abrogated by treatment with anti-NK1.1 mAb.
Discussion
The data presented indicates that NK cells of perforin-deficient mice have a decreased ability to reject class I-deficient BMC grafts. The defect was only detected in s.p.f. mice in a 7-day assay (Table 1 , Experiment 5), but was very apparent when the mice are bred in a conventional facility, e.g. the Microbiology Department Colony at the University of Texas Southwestern Medical Center in Dallas (Table 2) . Under the latter conditions, the 129:B6 PKO mice breed very well and do not have any increase in neonatal mortality or detectable infections or infestations as adults. The interesting and surprising finding is that mice with targeted genetic deficiencies and bred in a s.p.f. facility may not express loss of important host defense functions. The apparent slow and incomplete loss of ability to reject Tap-1 KO BMC grafts after transfer to the conventional colony could be due to the method of transfer used. We simply moved the mice into different cages and put them into the rooms. We did not put the PKO mice in cages with longterm 'residents' of the facility. We are presently transferring the mice from the s.p.f. facility into cages of BALB/c mice in the conventional facility to determine if loss of ability to reject will occur sooner due to transmission of some infectious entity from the conventionally bred animals. We have preliminary results from a study in which we add the antibiotics trimethoprim-sulfamethoxazole (Bactrim), polymyxin B and neomycin sulfate to the drinking water of conventionally housed 129:B6 PKO mice. In the first experiment, two of five of a cage of such mice were able to reject Tap-1 KO BMC within 1 month (data not shown).
There have been no systematic studies of marrow allograft reactivity in mice housed in conventional or s.p.f. facilities. Immunocompetence and resistance to tumor induction can be affected by the 'stress' of housing mice in conventional facilities and the mechanism can be largely due to high corticosterone blood levels (32) . Infection with viruses, the act of capturing mice and loud noises can raise the blood level of corticosterone within minutes. Our conventional colony is in a noisy corridor near to elevators and a loading dock of the Animal Resource Center in Dallas; the s.p.f. facilities are much quieter because of the limitation of access to a very few individuals. The stressful act of transporting mice in airplanes can suppress NK cell activity for a few days (33) . BALB/c mice in a s.p.f., but not in a conventional, facility are resistant to pristane-induced plasmacytomas (34) . This was interpreted to be due to a lack of antigen stimulation, because both athymic nude and nu/ϩ Swiss mice in a s.p.f. facility failed to develop plasmacytomas. There were no studies of NK cells, but one could postulate that host NK cells may contribute to resistance and that resistance is improved in a s.p.f. facility. BALB/c s.p.f. mice also have altered antibody responses to a soluble antigen (35) . We plan to test corticosterone levels in PKO mice housed in s.p.f. versus conventional facilities; however, the slow and incomplete loss of ability to reject Tap-1 KO BMC by transfer of PKO mice from s.p.f. to conventional rooms argues against that possibility.
Why did B6 PKO mice resist allogeneic BMC grafts so well (8)? There are two obvious possibilities. Firstly, the mice used were bred/housed in a s.p.f. environment, which prevented the effects of whatever inhibits NK cell functions of PKO mice in conventional environments. Secondly, B6 mice are excellent rejectors of allogeneic BMC grafts, because they inherit two or more 'good responder' genes (36) . One of those gene(s) maps to the NKR-P1/Ly-49 region of chromosome 6 (27) ; the other gene(s) affecting ability to reject BMC grafts has not been mapped. No genetic difference at NKR-P1/Ly-49 exists between B6 and 129:B6 PKO mice because the latter mice were selected for expression of NK1.1, i.e. they inherited the NKR-P1/Ly-49 complex of B6 origin. Therefore, these two strains have similar positive signaling (Ly-49D) and negative signaling (Ly-49A, C, G.2 and I) class I-specific receptors and similar NKR-P1 receptors that may influence NK cell function (37) (38) (39) and marrow allograft reactivity. In preliminary studies, we observed that s.p.f. 129:B6 H-2 b mice fail to reject allogeneic H-2 d BMC grafts. Because B6 PKO mice in a s.p.f. environment could reject H-2 d BMC (8) , it follows that at least one important genetic difference exists between B6 and 129:B6 PKO mice, i.e. between B6 and 129 strain mice. Genetic studies are in progress to map that potential 'resistance gene'. The housing environment also regulates the ability of B6 PKO mice to reject allogeneic BMC, because these mice in a conventional facility resist H-2 d BMC weakly (data not shown).
What might be the mechanisms of rejection of BMC grafts independent of perforin function or FasL-Fas interactions? We tested the possible influence of cytokines IFN-γ and IL-12 and receptors for TNF-α ( Table 1 ). The ability of IFN-γ KO mice to reject β 2 m KO BMC would seem to rule out that cytokine. Because these mice were in a s.p.f. environment and had intact perforin cytotoxicity functions, it is conceivable that the perforin system operated in those mice. Transfer of these mice to a conventional environment might elicit a defect in the ability to reject if IFN-γ is one of two mechanisms of rejection of BMC grafts. The same argument holds for IL-12; anti-IL-12 mAb had no effect on rejection, but the mice were in a s.p.f. environment (Table 1 ). The ability of PKO mice to reject β 2 m BMC after receiving antibodies to IFN-γ or IL-12 does cast some doubt on their importance in the rejection process. The TNF-RI/II KO mice were also able to reject β 2 m KO BMC, suggesting that TNF-α might not be critical for rejection. However, these mice were s.p.f., and the perforin and Fas systems were intact. Moreover, if NK cells themselves secrete TNF-α to reject BMC, a defect in TNF-R may not be relevant, i.e. it would be a lack of TNF-R on target BMC that might affect rejection. On the other hand, if NK-macrophage cell interactions are critical (40) , a lack of TNF-R could be important, e.g. the macrophages might stimulate NK cells via cell-bound or secreted TNF-α. There are two newly described members of the TNF-R family, DR3 and DR4, both of which are expressed in lymphoid tissues (41, 42) . These molecules, once bound, can lead to apoptosis and therefore are candidates worth testing.
The one reliable variable was the use of anti-NK1.1 mAb (Tables 1 and 2 ). The effect of these PK136 antibodies strongly suggests that NK cells were the effectors, despite evidence that NK/T cells might be involved in marrow allograft rejection (43) . Because the donor BMC were class I deficient, it is not likely that CD8 ϩ T cells function in this system. The tentative conclusion of this set of experiments is that the environment can influence the function of NK cells deficient in perforin. A similar observation was made, i.e. autoimmune hemolytic anemia was induced, in mice transgenic for a TCR gene responsive to syngeneic red blood cells in conventional but not in s.p.f. housing facilities (44) . Therefore, one must assess the role of the housing environments of mice with genetic defects in immune functions before concluding they do or do not have biological consequences. In human bone marrow transplantation, patients are treated with antibiotics, maintained in laminar-flow rooms and aseptic methods are used for care, especially in the first weeks after irradiation and marrow cell transfer. These are conditions that may affect the ability of the recipient to reject allogeneic marrow cell grafts.
There is evidence that T cell-mediated solid and tumor allograft rejection, and anti-viral responses are normal or nearnormal in PKO host mice (45) (46) (47) (48) . Moreover, the ability of donor T cells to mediate graft versus host reactions is only moderately affected by lack of perforin (49, 50) . These data at least suggest that perforin may not be an important host defense mechanism. However, perforin-deficient mice have deficient cytotoxic T lymphocyte responses to LCMV and eliminate fibrosarcoma cells inefficiently (3), and are exquisitely sensitive to transplants of RMA-S tumor cells that are normally sensitive to NK cells and to various other forms of tumor surveillance (51, 52) . Therefore, this cytotoxic system is important in host defense, but there are 'back-up' mechanisms that preserve host immunological resistance to diseases. These latter mechanisms may be vulnerable to failure in certain housing environments. Use of both s.p.f. and conventional housing environments may reveal biological defects in gene KO mice otherwise missed by only using the often recommended s.p.f. facilities (32) .
